An amoeba to help the eco-industry

Willaertia magna C2c Maky

Amoéba develops applications by exploiting the characteristics of the amoeba Willaertia magna C2c Maky. This amoeba has been isolated from the environment and has natural properties.

Discover
Investor

Lastest news


28 August 2024

AMOEBA prepares for the commercial launch of the AXPERA Product Line in the USA with approval expected by 2025

Amoéba, an industrial greentech specialising in the development of natural microbiological solutions based on the patented use of amoebae, announces that the US Environmental Protection Agency (US EPA) has confirmed the admissibility and completeness of the registration dossier for its biocontrol products in the United States.


2 July 2024

A new legal structure to maximise commercial activities

Amoéba , an industrial greentech specialising in the treatment of microbiological risk, announces a major legal reorganisation designed to strengthen the development of its commercial activities in the biocontrol and cosmetics sectors, and to create value for its shareholders.


10 June 2024

Confirmation of the development potential of Amoeba in cosmetics

Amoeba, an industrial greentech specialised in the treatment of microbiological risk, developing a biocontrol agent for the protection of plants in agriculture and a range of cosmetic ingredients, announces that it has received the results of the clinical study confirming the interest of using its ingredient in cosmetic as a skin care product.


2 May 2024

Amoéba’s Board of Directors renewed to support the company’s new strategic ambitions

Amoéba, an industrial biotech specialised in the treatment of microbiological risk, developing a biocontrol agent for the protection of plants in agriculture and a range of anti-ageing cosmetic ingredients, is appointing a new Board of Directors, welcoming four well-known figures specialised in the fields that represent the company’s core activities.

Discover the news

Business

Amoéba is a Lyonnaise greentech, an innovative player in the treatment of bacterial risk.

At the crossroads of environmental protection and public health issues, we are developing a three-fold scientific, industrial and commercial expertise. The company is developing around multiple applications using the amoeba Willaertia magna C2c Maky in the prevention of microbiological risk for water treatment, human wounds and plant protection.

Discover

Biocontrol

Plants protection

We found that mechanically lysed amoeba Willaertia magna C2c Maky exhibited strong fungicidal properties.

First on oomycetes (microorganisms close to fungi and responsible for mildews) then on phytopathogenic fungi such as rusts, powdery mildew, etc.

This has been demonstrated in laboratory tests and then, since 2019, has been verified in field trials.

Learn more

Biocide

The only biological biocide that can be used in air cooling towers, with no hazard class for human health and the environment.

Water treatment

Our disruptive biocide helps control the level of Legionella, both those present in the water and those colonizing the biofilm.

The effectiveness of the biocide is due to the natural properties of the amoeba Willaertia magna C2c Maky, which predates pathogenic bacteria and other free-standing amoebae.

For the first time in 50 years of industrial water treatment, Amoéba is giving industry the opportunity to choose a responsible alternative.

Learn more

Testimonials

The industry professionals testify about their experiences with the biological biocide BIOMEBA.

Dalkia

Jean-Michel CLAUDE

Vitacuire

Yves GAGNE

Häagen Dazs

Olivier BERTRAND
All our testimonials

Research & Development

Other research is currently being conducted in order to make the best use of Willaertia magna C2c Maky’s different properties.

These properties open up a wide range of applications, particularly at the interface between health and environment fields.

All about it
‘’ A UNIQUE MICRO-ORGANISM ‘’